Effect of Induced Hypoglycemia on Inflammation and Oxidative Stress in Type 2 Diabetes and Control Subjects
Authors
Affiliations
Intensive diabetes control has been associated with increased mortality in type 2 diabetes (T2DM); this has been suggested to be due to increased hypoglycemia. We measured hypoglycemia-induced changes in endothelial parameters, oxidative stress markers and inflammation at baseline and after a 24-hour period in type 2 diabetic (T2DM) subjects versus age-matched controls. Case-control study: 10 T2DM and 8 control subjects. Blood glucose was reduced from 5 (90 mg/dl) to hypoglycemic levels of 2.8 mmol/L (50 mg/dl) for 1 hour by incremental hyperinsulinemic clamps using baseline and 24 hour samples. Measures of endothelial parameters, oxidative stress and inflammation at baseline and at 24-hours post hypoglycemia were performed: proteomic (Somalogic) analysis for inflammatory markers complemented by C-reactive protein (hsCRP) measurement, and proteomic markers and urinary isoprostanes for oxidative measures, together with endothelial function. Between baseline and 24 -hours after hypoglycemia, 15 of 140 inflammatory proteins differed in T2DM whilst only 1 of 140 differed in controls; all returned to baseline at 24-hours. However, elevated hsCRP levels were seen at 24-hours in T2DM (2.4 mg/L (1.2-5.4) vs. 3.9 mg/L (1.8-6.1), Baseline vs 24-hours, P < 0.05). In patients with T2DM, between baseline and 24-hour after hypoglycemia, only one of 15 oxidative stress proteins differed and this was not seen in controls. An increase (P = 0.016) from baseline (73.4 ng/mL) to 24 hours after hypoglycemia (91.7 ng/mL) was seen for urinary isoprostanes. Hypoglycemia resulted in inflammatory and oxidative stress markers being elevated in T2DM subjects but not controls 24-hours after the event.
Niinuma S, Habib H, Takemoto A, Das P, Sathyapalan T, Atkin S Cells. 2025; 14(5).
PMID: 40072105 PMC: 11898917. DOI: 10.3390/cells14050377.
Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome.
Nandakumar M, Das P, Sathyapalan T, Butler A, Atkin S Biomolecules. 2025; 15(1).
PMID: 39858399 PMC: 11763313. DOI: 10.3390/biom15010004.
Butler A, Nandakumar M, Sathyapalan T, Brennan E, Atkin S Int J Mol Sci. 2025; 26(1.
PMID: 39796177 PMC: 11720512. DOI: 10.3390/ijms26010321.
Zhang J, Pollard A, Pearson E, Carling D, Viollet B, Ellacott K Diabet Med. 2024; 42(3):e15456.
PMID: 39717018 PMC: 11823358. DOI: 10.1111/dme.15456.
PCSK7 levels in women with and without PCOS.
Atkin S, Butler A, Jamialahmadi T, Sahebkar A J Clin Transl Endocrinol. 2024; 38:100376.
PMID: 39691660 PMC: 11650127. DOI: 10.1016/j.jcte.2024.100376.